Drug-labels.com

Cyclophosphamide for Injection (Accord Healthcare): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Pre Market
Strength:
500 mg, 1000 mg, 2000 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - Cyclophosphamide for Injection (Accord Healthcare)

ABOUT THIS MEDICATION

What the medication is used for:

Cyclophosphamide for Injection can be used alone or in combination with other medication to treat:

  • Malignant lymphomas
  • Multiple Myelomas
  • Leukemias
  • Mycosis Fungoides (Advanced disease)
  • Neuroblastoma (in patients with disseminated disease, Stage IV)
  • Carcinoma of the Breast (Stages II-IV)
  • Retinoblastoma (St.Jude Stages II-IV)
  • Malignant neoplasms of the lung

What it does:

Cyclophosphamide interferes with the growth of cancer cells by slowing their growth and spread in the body.

Cyclophosphamide may also affect the growth of normal body cells. This could lead to undesirable side effects.

When it should not be used:

Cyclophosphamide for Injection should not be used if you have:

  • allergy to Cyclophosphamide
  • obstruction to urine flow manifested as difficulty with urination
  • severe suppression of bone marrow function
  • severe kidney problems
  • severe liver problems
  • active infection/suppressed immune system

What the medicinal ingredient is:

Cyclophosphamide

What the important nonmedicinal ingredients are:

Mannitol.

What dosage forms it comes in:

Cyclophosphamide for Injection is available as a sterile powder for injection supplied in 30 mL, 50 mL, and 100 mL vials.

WARNINGS AND PRECAUTIONS

Serious Warnings and Precautions Cyclophosphamide for Injection should only be used under supervision of a doctor who is experienced in the use of anti-cancer drugs. Serious side effects that may occur with Cyclophosphamide for Injection include:

  • Causing other types of cancers with long term use;
  • Cardiac toxicity;
  • Severe QT/QTc prolongation (disturbances in heart rhythm);
  • Lung injury;
  • Liver injury;
  • Increased kidney and bladder injury;
  • Serious allergic reaction;
  • Vaccine induced infection when used in patients who have received live-vaccine

Cyclophosphamide for Injection can affect depolarizing muscle relaxants such as succinylcholine.

Cyclophosphamide for Injection should not be given to patients with low white blood cell and platelet count.

BEFORE you use Cyclophosphamide for Injection, talk to your doctor or pharmacist if:

  • You have any of the following conditions:

    • Previously received radiation therapy;
    • QT/QTc prolongation or family history of QT/QTc prolongation;
    • Electrolyte problems or conditions that could lead to electrolyte disturbances;
    • Cancer that has spread to the brain;
    • Low white blood cell count;
    • Low platelet count;
    • Low red blood cell count;
    • Cancer that has spread to the bone marrow;
    • Liver problems;
    • Kidney problems;
    • Difficulty urinating:
    • Cystitis (bladder infection);
    • Active infections;
    • Abnormal serum creatinine;
  • You have had surgery in the previous 10 days, or have any upcoming surgery, including dental surgery; Cyclophosphamide for Injection may prevent normal wound healing.
  • You are going to receive any vaccine.
  • You are pregnant or likely to become pregnant or are nursing a baby.

  • You are male and are likely to father a child.
  • You have any allergies to this drug or its ingredients
  • Cyclophosphamide for Injection is not recommended for use in patients under 16 years of age.
  • Cyclophosphamide for Injection may cause harm to an unborn baby.

    Female patients should use an effective birth control method while using Cyclophosphamide for

Injection. Male patients should not father a child while using Cyclophosphamide for Injection and for at least 6 months after the last dose of Cyclophosphamide for Injection.

  • Cyclophosphamide for Injection may cause sterility in both male and female patients.
  • Do not breast feed while taking Cyclophosphamide for Injection, the drug can get into the breast milk, and therefore, into the baby.

INTERACTIONS WITH THIS MEDICATION

Before and while taking Cyclophosphamide for Injection you should tell your doctor or pharmacist about your other prescription and non- prescription medications, vitamins, nutritional supplements and herbal products you are taking or plan to take.

This list shows some of the drugs (and their common use) and some procedures that may interact with Cyclophosphamide for Injection. Many medications may interact with Cyclophosphamide for Injection, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list.

  • Alcohol

  • Antibiotics (eg. ciprofloxacin, metronidazole, rifampin, chloramphenicol, sulfonamides)
  • Anticoagulants such as warfarin (Coumadin)
  • Antidepressants (eg. St. John’s wort, bupropion)
  • Anti-fungals (fluconazole, itraconazole)
  • Cimetidine (for acid reduction)
  • Corticosteroids such as prednisone
  • Medications to aid in the management of selected chronic alcohol patients (disulfiram)
  • Medications to treat rheumatoid arthritis (etanercept, indomethacin)
  • Lovastatin (for high cholesterol)
  • Medications to treat gout (allopurinol)
  • Medications to treat seizures (eg. phenytoin, carbamazepine, phenobarbital)
  • Medications to treat high blood pressure such as ACE inhibitors and thiazide diuretics (e.g. hydrochlorothiazide)
  • Medications to treat heart problems and abnormal heart rhythm (eg. amiodarone, digoxin, prasugrel, verapamil)
  • Medications to prevent vomiting (eg. aprepitant, ondansetron)
  • Medications to stimulate the bone marrow (eg. G-CSF, GM-CSF)
  • Medications to treat cancers (e.g. busulfan, tamoxifen)
  • Medications that modulate immune system (eg. cyclosporine, azathioprine, methotrexate)
  • Sedatives (eg. chloral hydrate, benzodiazepines)
  • Medications to treat diabetes (sulfonylureas)
  • Medications to treat HIV (protease inhibitors, zidovudine)
  • Vaccines, especially live-vaccines
  • Previous irradiation of the cardiac region

PROPER USE OF THIS MEDICATION

Your doctor will determine what dose of Cyclophosphamide for Injection is right for you and how often you should receive it.

Cyclophosphamide for Injection is to be given into the vein.

It is important to drink extra fluids to help prevent kidney and bladder problems.

Overdosage:

In case of drug overdose, contact a healthcare professional, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

Missed Dose:

If you miss your scheduled treatment, contact your doctor or nurse as soon as possible to schedule your next treatment.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Cyclophosphamide can sometimes cause side effects such as blood problems, loss of hair, and problems with the bladder. Also, because of the way the drug acts on the body, there is a chance that it might cause other unwanted effects that may not occur until months or years later. These may include certain types of cancer, such as leukemia. Discuss these possible effects with your doctor.

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
CommonAnemia√
Blood in Urine√
Central Nervous System Troubles*√
Fever or fever with low white cell count√
Infection√
Kidney problems√
Liver problems√
Loss of Appetite√
Loss of Hair√
Low platelet count√
Low white cell count√
Nausea/ Vomiting√

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
Urinary problems√
Vein inflammation√
UncommonDiarrhea√
Fatigue√
Heart troubles√
Low blood pressure√
Malaise√
Mouth inflammation√
Papular rash√
Peripheral neuropathy**√
Skin inflammation√

* For example Dizziness, Confusion, Convulsions, Headache

** For example, numbness of the hands and feet.

This is not a complete list of side effects. For any unexpected effects while taking Cyclophosphamide for Injection, contact your doctor or pharmacist.

HOW TO STORE IT

Store between 2° to 8°C (36° to 46°F); Do not freeze. Protect from direct light.

Keep out of reach and sight of children.

REPORTING SIDE EFFECTS

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

If you want more information about Cyclophosphamide for Injection:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for

    • healthcare professionals and includes this Consumer Information by visiting the Health Canada website (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); or by calling the sponsor Accord Healthcare Inc. at 1-866-296-0354.

Accord Healthcare, Inc.,

3535 boul. St. Charles, Suite 704

Kirkland, QC, H9H 5B9

Canada

Last revised: September 14, 2022

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02531011

Revision date stated in the text: September 14, 2022

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Cyclophosphamide for Injection (Accord Healthcare)

Rx or OTC
Prescription (Rx)?
DIN 02531011, 02531038, 02531046
Schedule(s) PRESCRIPTION
Active ingredient(s) Cyclophosphamide
Dosage form(s) Powder For Solution
Route(s) of administration Intravenous
Drug class (WHO ATC)
  1. L Antineoplastic and immunomodulating agents
    1. L01 Antineoplastic agents
      1. L01A Alkylating agents
        1. L01AA Nitrogen mustard analogues
          1. L01AA01 Cyclophosphamide
Company ACCORD HEALTHCARE INC
Current status Cancelled Pre Market
Current status date June 9, 2025
Strengths and forms
DIN Strength Dosage form(s) Current status
02531011 500 MG Powder For Solution Cancelled Pre Market June 9, 2025
02531038 1000 MG Powder For Solution Cancelled Pre Market June 9, 2025
02531046 2000 MG Powder For Solution Cancelled Pre Market June 9, 2025

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.